facebook pixel
chevron_right Trending_Health
transparent
Takeda to build $106M vaccine plant for dengue vax push
Japan's Takeda is making a big push with a vaccine for dengue and says to be prepared it will build a EUR100 million plant at its manufacturing site in Singen, Germany. The announcement comes as the drugmaker begins a massive, 20,000-patient phase 3 study in Asia and Latin America of its dengue vaccine candidate. Global Dengue Program Medical Director Derek Wallace told FiercePharmaManufacturing that the company has had to build out its entire vaccine operation for this undertaking.

Want to stay updated ?

x

Download our Android app and stay updated with the latest happenings!!!


50K+ people are using this